Abcam Is A Global Leader In Proteomicsspecializing In High Quality Biological Reagents And Tools For Life Science Research And Clinical Applicationsfounded In 1998 In Cambridgeukthe Company Initially Focused On Sourcing And Selling Research Antibodies Onlineover The Yearsabcam Has Expanded Its Product Offerings To Include Multiplex And Mirna Assaysin Vitro Recombinant Monoclonal Antibodiesand Various Immunoassay Capabilities The Company Provides A Wide Range Of Productsincluding Primary And Secondary Antibodiesconjugated Antibodiessingleplex Immunoassayspeptidesproteinsknockout Cell Linesand Cellular Activity Kitsabcam Supports Over 750 000 Researchers In More Than 130 Countriescontributing To Advancements In Fields Such As Cancer Researchneurological Disordersand Infectious Diseasesin 2023Abcam Was Acquired By Danaher Corporationfurther Enhancing Its Position In The Life Sciences Industry
